RPG Life Sciences Board Meeting on July 28, 2026 for Q1 Results

RPG Life Sciences Ltd has announced that its Board of Directors will convene on July 28, 2026. The primary agenda items include the consideration and approval of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with taking on record the Limited Review Report. Concurrently, the company has implemented a trading window closure for its designated persons and their immediate relatives, effective from July 1, 2026, until 48 hours post the public announcement of the financial results.